Evaluation of desmopressin in preventing overcorrection of hyponatraemia among patients with renal dysfunction.

Mabie K, Smith BA, Chase A, Henry KR

Open source

DOI
10.1136/ejhpharm-2025-004693
Published
2026 Oct 23
Container
European journal of hospital pharmacy : science and practice
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/ejhpharm-2025-004693,
  title = {Evaluation of desmopressin in preventing overcorrection of hyponatraemia among patients with renal dysfunction.},
  author = {Mabie K and Smith BA and Chase A and Henry KR},
  year = {2026},
  journal = {European journal of hospital pharmacy : science and practice},
  doi = {10.1136/ejhpharm-2025-004693},
  url = {https://doi.org/10.1136/ejhpharm-2025-004693}
}

RIS

TY  - JOUR
TI  - Evaluation of desmopressin in preventing overcorrection of hyponatraemia among patients with renal dysfunction.
AU  - Mabie K
AU  - Smith BA
AU  - Chase A
AU  - Henry KR
PY  - 2026
JO  - European journal of hospital pharmacy : science and practice
DO  - 10.1136/ejhpharm-2025-004693
UR  - https://doi.org/10.1136/ejhpharm-2025-004693
ER  - 

APA

K, M., BA, S., A, C., & KR, H. (2026). Evaluation of desmopressin in preventing overcorrection of hyponatraemia among patients with renal dysfunction.. European journal of hospital pharmacy : science and practice. https://doi.org/10.1136/ejhpharm-2025-004693

Source records